Apyx Medical Corporation (APYX) vs Genelux Corporation (GNLX)
A side-by-side comparison of Apyx Medical Corporation and Genelux Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APYX
Apyx Medical Corporation
$2.60HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
GNLX
Genelux Corporation
$2.60HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — APYX vs GNLX
growth of $100 · dividends reinvested · last 4yAPYX -14.5% (-3.8%/yr)GNLX -57.7% (-19.4%/yr)APYX compounded faster over this window
APYX GNLX
APYX vs GNLX: by the numbers
- •GNLX is the larger company ($117M vs $109M market cap).
- •Both run net losses; APYX's is the smaller (-14.78% vs -422412.50% net margin).
Metrics side by side
Valuation
| Metric | APYX | GNLX |
|---|---|---|
| P/S ratio | 1.87 | 14573.14 |
| P/B ratio | 10.27 | 7.24 |
Profitability
| Metric | APYX | GNLX |
|---|---|---|
| Gross margin | 33.94% | -7075.00% |
| Operating margin | -6.06% | -415175.00% |
| Net margin | -14.78% | -422412.50% |
| ROE | -80.97% | -209.73% |
| ROIC | -6.84% | -192.18% |
Growth (annualized)
| Metric | APYX | GNLX |
|---|---|---|
| Revenue CAGR (5Y) | 8.82% | N/A |
| Total return CAGR (5Y) | -28.10% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.